I posted all this in different from days ago. Dont you love these linear threads . You get lost in them. Maybe no one reads mine. lol
Heres my post . It deserves to be said again.
forbes40
Post #: 4214498
Price at time of posting: $1.195
In Reply to msg: #4214380
IP: 211.31.xxx.xxx
Sentiment: ST Buy
Disclosure: Stock Held
Views: 372
Trader
well the people who sold today on this news or not even bothering to know this news are just plain STUPID.
Ultimately the share market is about taking money off the stupid. A redistribution of wealth.
Can you seller dumbnuts understand what the CDC advisory committee are saying here.
''ATLANTA, June 29 -- Zanamivir (Relenza), a neuraminidase inhibitor, should be the preferred treatment for patients with influenza-like illness, whether infection is caused by a seasonal virus or the pandemic H1N1 virus, an advisory committee to the CDC said''
My god this is WORTH BILLIONS to GSK and Hundreds of Millions to BTA. Lucky bastards. And thats not even counting the awesome pipeline like the cure for the common cold and super relenza(LANI).
Watch the pressure on the relenza delivery method to be fast tracked.
- Forums
- ASX - By Stock
- BTA
- cdc says relenza now the preferred treatment
cdc says relenza now the preferred treatment, page-3
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online